AN KHANG PHARMA PHARMACY JOINT STOCK COMPANY

Unlike the steady, brand-anchored profile of Vietnam Liwayway, AN KHANG PHARMA PHARMACY JOINT STOCK COMPANY presents itself as a fast-moving, expansion-driven retail story, shaped by scale ambitions rather than product heritage.

Legally registered on 21 August 2017 under Business Registration Number 0314587300, An Khang Pharma operates as a joint stock company headquartered at 128 Tran Quang Khai Street, Tan Dinh Ward, Ho Chi Minh City. The company is best known for operating the An Khang Pharmacy chain, focusing on retail distribution of pharmaceuticals, medical goods, cosmetics, and consumer health products through specialized stores. It is a privately held enterprise, wholly owned by Dien May Xanh Investment Joint Stock Company, placing it firmly within a larger domestic retail ecosystem.

Operational leadership is centralized under Doan V. H. E., General Director, reflecting a management model closely aligned with rapid rollout and network expansion rather than decentralized store autonomy.

Financially, An Khang Pharma tells a bold but demanding story. By 2023, the company had pushed total sales to approximately USD 90.4 million, up more than 43% year-on-year, alongside a sharp rise in assets and equity. However, this growth came at a cost: the company reported a net loss of USD 14.2 million, extending losses from the previous year. This indicates a strategy that prioritizes market penetration, store expansion, and customer acquisition while accepting short-term pressure on profitability.

In essence, An Khang Pharma is not yet a mature cash generator. It is a scale-first retail platform, trading earnings today for footprint tomorrow—a profile that demands careful attention to funding capacity, cost control, and the timeline toward breakeven.